Renaissance Technologies - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2020. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2021$773,000
+8488.9%
822,655
+4708.3%
0.00%
Q2 2020$9,000
-91.7%
17,109
-56.0%
0.00%
Q2 2016$109,000
-38.4%
38,907
+34.6%
0.00%
Q1 2016$177,000
+124.1%
28,900
+97.9%
0.00%
Q4 2015$79,00014,6000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Capital CS Group, LLC 75,669$38,0000.04%
Founders Capital Management 18,000$9,0000.01%
Verdence Capital Advisors LLC 58,382$29,0000.00%
WOLFF WIESE MAGANA LLC 10,740$5,0000.00%
TWO SIGMA SECURITIES, LLC 93,669$47,0000.00%
Affinity Capital Advisors, LLC 13,180$7,0000.00%
Tower Research Capital LLC (TRC) 171,928$86,0000.00%
B. Riley Wealth Advisors, Inc. 25,210$13,0000.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 100,000$50,0000.00%
MGO ONE SEVEN LLC 10,615$5,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders